Director, Payer Access Cell Therapy

About   Iovance Biotherapeutics, Inc.   Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com . Overview As we continue our strategic execution with the launch of Amtagvi and for future indication preparation, we are seeking experienced Payor & Access Cell Therapy leaders who will formulate and execute strategic account plans engaging Regional and National payors and targeted hospitals / health systems / large group practices. This person will be responsible for ensuring positive payor medical policies, Authorized Treatment Center (ATC), reimbursement preparation and continued support, and close partnership with field sales team members pertaining to their specific customer needs. Strong collaboration skills is a must as this role will require you to engage in several cross-functional engagements with Medical Affairs, Legal, Field Sales, External Affairs and Marketing as required. Essential Functions and Responsibilities • Responsible for assigned regional and national payor engagement including informing strategy and execution to support product value proposition, quality coverage, coding and reimbursement. Targeted payer accounts to include national, regional commercial, and government insurers. • Develop business champions to instill confidence in a financially viable TIL service line within the targeted hospitals / health systems / large group practices. • Ensure appropriate payer policies aligned to label, NCCN Guidelines, and/or clinical trial criteria to optimize patient access to Iovance products. • Preparation of the payer marketplace for future product indications with updated clinical data and support payer adjudication process needs to support an evolving provider access landscape for Amtagvi. • Pull through with the providers and the payers on identified clinical needs per corporate initiatives with Amtagvi. • Accountable for partnerships with targeted hospitals / health systems /large group practices to plan for their financial processes needs and ensure timely patient access for Iovance products. • Responsible for C-Suite Relationships through FDAMA 114 at the Provider Accounts including hospital ATCs & Community Oncology Groups and their associated individual community oncology treating centers. • Collaborate with IovanceCares Case Management and Field Sales team to address and resolve access issues to assure quick pull through of patients. • Track key metrics to ensure accuracy of executive dashboar